BioSpace News Archive

Press Releases

Galderma Delivers Record Net Sales of 3.737 Billion USD in the First Nine Months of 2025 and 15.0% Year-on-Year Growth at Constant Currency, Raises Full-Year Guidance

October 23, 2025
·
17 min read
Press Releases

Tonix Pharmaceuticals Announces First Patient Dosed in the Investigator-Initiated FOCUS Study of Tonix’s Intranasal Potentiated Oxytocin in AVP-D Conducted by Massachusetts General Hospital

October 23, 2025
·
15 min read
Press Releases

Galera Therapeutics Announces Acquisition of Dismutase Mimetics Portfolio by Toronto-based Biossil for up to $105 Million

October 23, 2025
·
6 min read
Press Releases

Electra Therapeutics Announces First Patients Dosed in the SURPASS Phase 2/3 Pivotal Study of ELA026 in Secondary Hemophagocytic Lymphohistiocytosis (sHLH)

October 23, 2025
·
4 min read
Press Releases

Electra Therapeutics Receives FDA Breakthrough Therapy and EMA Priority Medicines Designations for ELA026 in Secondary Hemophagocytic Lymphohistiocytosis (sHLH)

October 23, 2025
·
3 min read
Press Releases

Electra Therapeutics Announces $183 Million Series C Financing to Advance First-in-Class SIRP-Targeted Therapies for Immune Disorders and Cancer

October 23, 2025
·
4 min read
Press Releases

Nurix Therapeutics Announces $250.0 Million Registered Offering of Common Stock

October 23, 2025
·
5 min read
Press Releases

Axsome Therapeutics to Participate in Upcoming November 2025 Investor Conferences

October 23, 2025
·
4 min read
Press Releases

NRG Therapeutics Announces Senior Appointments as it Advances NRG5051 Towards First-in-Human Clinical Studies

October 23, 2025
·
5 min read
Press Releases

Appili Therapeutics to Attend BARDA Innovation Symposium 2025

October 23, 2025
·
5 min read